CTOs on the Move

OmniSYS

www.omnisys.com

 
OmniSYS is a technology company with 25+ years of experience working with pharmacies, payers, providers and pharmaceutical manufacturers. We leverage this unique market insight along with our pharmacy workflow expertise to deliver valuable solutions that help pharmacies thrive in the changing pharmacy landscape. Our solutions help pharmacies engage patients, grow clinical services and improve financial performance. OmniSYS currently serves over 25,000 pharmacies, connects to hundreds of payers and touches millions of patient lives.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.omnisys.com
  • 15950 Dallas Parkway Suite 350
    Dallas, TX USA 75248
  • Phone: 214.459.2574

Executives

Name Title Contact Details

Similar Companies

CalorieKing Wellness Solutions

CalorieKing Wellness Solutions is a El Cajon, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Laurel Health System

Laurel Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Laurel Health System is based in Wellsboro, PA. You can find more information on Laurel Health System at www.laurelhs.org

Meadows Regional Medical Center

Meadows Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Meadows Regional Medical Center is based in Vidalia, GA. You can find more information on Meadows Regional Medical Center at www.meadowsregional.org

Lifemasters Supported Selfcare

Lifemasters Supported Selfcare is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lifemasters Supported Selfcare is based in South San Francisco, CA. You can find more information on Lifemasters Supported Selfcare at www.lifemasters.net

MSI

MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).